TB Online is no longer maintained. This is an archive of the site. For news on TB please go to: https://globaltbcab.org/

News

Brief news reports on Tuberculosis

GlaxoSmithKline to open clinical trials data and TB library to outside researchers

GlaxoSmithKline said it will make clinical trial data available to other researchers, breaking from the practice of other pharmaceutical companies which claim such data as proprietary business information.

Read More →

PEPFAR releases FY13 country operational plan guidance

PEPFAR has released its "Fiscal Year 2013 Country Operational Plan (COP) Guidance" on its website. The document (.pdf) provides guidance with respect to COP preparation; priorities and approaches for FY 2013; mandatory earmarks and reporting requirements; COP elements; as well as management and operations (October 2012).

Read More →

Indian bureaucracy slows treatment of tuberculosis

Rahima Sheikh, an Indian tuberculosis patient carrying a nearly untreatable strain of the disease, is perilously close to running out of the medicines that appear to be saving her life.

Read More →

Establishment of the African Community Advisory Board (AfroCAB)

The AfroCAB will promote the advancement of the issues affecting people living with HIV in Africa.

Read More →

Tracking TB-HIV coinfection in the United States

A recent tuberculosis (TB) report from the Centers for Disease Control and Prevention (CDC) found that fewer people in the United States have TB disease than in years past. A total of 10,528 TB cases were reported in the United States in 2011, a decrease from 11,171 cases in 2010. Despite this decrease in reported TB cases in 2011, the disease still remains a serious threat, especially for people living with HIV, as HIV can make TB worse. Worldwide, TB is one of the leading causes of death among people living with HIV.

Read More →

Efavirenz interaction studies with TB compounds bedaquiline and delamanid

Two poster presentations at ICAAC described potential reduced exposure of bedaquiline and a lack of interaction with delamanid when co-administered with efavirenz (EFV).

Read More →

The future of TB in the United States: Going, or growing?

Yet the U.S., long a leader in TB elimination efforts, is in jeopardy of losing ground in the struggle to get to zero.

Read More →

Important advances in TB drug development

Three recent studies have significantly advanced TB drug development.

Read More →

Curing TB in Europe is more about politics than science

Despite being considered as a disease of the past, tuberculosis (TB) kills seven people in Europe every hour and, worryingly, rates of multi drug resistant TB (MDR-TB) in the region are the highest in the world. With 81,000 MDR-TB cases in 2010 alone, the European region accounts for nearly 20 % of the global burden.

Read More →

Southern African declaration targets TB in mining sector

15 southern African countries have recently pledged to improve treatment and care for current and former miners with tuberculosis and their families. Adele Baleta reports from Cape Town.

Read More →

Page 802 of 895 · Total posts: 10

←First 801 802 803 Last→